Serious bradycardia and remdesivir for coronavirus 2019 (COVID-19): a new safety concerns

OBJECTIVES: In recent clinical trials some cardiac arrhythmias were reported with use of remdesivir for COVID-19. To address this safety concern, we investigated whether use of remdesivir for COVID-19 is associated with an increased risk of bradycardia. METHODS: Using VigiBase®, the World Health Org...

Descripción completa

Detalles Bibliográficos
Autores principales: Touafchia, Anthony, Bagheri, Haleh, Carrié, Didier, Durrieu, Geneviève, Sommet, Agnès, Chouchana, Laurent, Montastruc, François
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. 2021
Materias:
Research Note
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7910147/
https://www.ncbi.nlm.nih.gov/pubmed/33647441
http://dx.doi.org/10.1016/j.cmi.2021.02.013

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7910147/
https://www.ncbi.nlm.nih.gov/pubmed/33647441
http://dx.doi.org/10.1016/j.cmi.2021.02.013

Ejemplares similares